e8-k
 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  October 15, 2001

United Therapeutics Corporation


(Exact Name of Registrant as Specified in Charter)
         
Delaware 0-26301 52-1984749



(State or Other Jurisdiction of Incorporation) (Commission
File Number)
(I.R.S. Employer
Identification Number)
         
1110 Spring Street
Silver Spring,
20910


(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code:

(301) 608-9292



 

Item 5. Other Events.

      On October 15, 2001, the Registrant issued a press release attached hereto as Exhibit 99 and incorporated herein.

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

         
Exhibit No. Description of Exhibit


 
99 Press release of October 15, 2001


 

SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  United Therapeutics Corporation
(Registrant)
             
Date: October 15, 2001 By: /s/ Fred T. Hadeed

Name:
Title:
Fred T. Hadeed Chief Financial Officer


 

Exhibit Index

         
Exhibit No. Description of Exhibit


99 Press release of October 15, 2001